Login / Signup

Financial toxicity from newly approved second-/third-line agents in metastatic urothelial carcinoma.

David J BenjaminMark P LythgoeArash Rezazadeh
Published in: BJU international (2023)
Keyphrases
  • squamous cell carcinoma
  • small cell lung cancer
  • drug administration
  • oxidative stress
  • affordable care act
  • healthcare